Inxight Informatics System - Repository of Therapeutic Hypotheses

Inxight 信息学系统 - 治疗假设存储库

• 批准号: 10262720
• 负责人: Noel Southall
• 金额: $ 298.65万
• 依托单位: NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10262720
• 关键词: Address; Algorithms; Antibodies; Authorization documentation; Biological; Clinical; Collection; Data; Data Aggregation; Data Set; Disease; Food Supply; Informatics; Intervention; Investigation; Label; Manuals; Marketing; Medical; Methods; Molecular Target; Names; Natural Products; Non-Prescription Drugs; Oligonucleotides; Pharmaceutical Preparations; Pharmacologic Substance; Pharmacology; Privatization; Public Domains; Publishing; Research Personnel; Resources; Source; System; Therapeutic; Time; Translational Research; United States Food and Drug Administration; Update; data resource; design; drug development; drug market; drug resource; novel; repository; small molecule; tool; web portal

NCATS has developed Inxight data resources to facilitate translational research. All facts appearing in these datasets are in the public domain and may be reproduced or copied without NCATS permission. Citation of the source is appreciated. Drugs offers a substantial amount of manually curated data from multiple independent, public sources. These include updated information from the NCATS Pharmaceutical Collection as well as data published from the Food and Drug Administration (FDA) for the first time. NCATS Inxight: Drugs incorporates and unifies a wealth of data, including manually curated data supplied by the FDA and private companies, and provides marketing and regulatory status, rigorous drug ingredient definitions, biological activity, clinical use, and more.

NCATS开发了Inxight数据资源，以促进转化研究。这些数据集中出现的所有事实都属于公共领域，未经NCATS许可，可以复制或复制。引用的来源是赞赏。 药物提供了大量来自多个独立公共来源的手动管理数据。其中包括来自NCATS Pharmaceutical Collection的最新信息以及美国食品药品监督管理局（FDA）首次发布的数据。 NCATS Inxight：Drugs整合并统一了大量数据，包括由FDA和私营公司提供的手动管理数据，并提供营销和监管状态，严格的药物成分定义，生物活性，临床使用等。